Newborn Screening Market, By Product (Instruments, Assay Kits, Reagents), By Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, Others), By Application (Phenylketonuria, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease,

Newborn Screening Market, By Product (Instruments, Assay Kits, Reagents), By Test Type (Dry Blood Spot Test, Cardiac Test, Hearing Test, Urine Test, Others), By Application (Phenylketonuria, Critical Congenital Cardiac Disease, Maple Syrup Urine Disease, Hearing Disability, Sickle Cell Disease, Others), By End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Newborn screening includes various tests, such as hearing tests, urine tests, dry blood tests, and others, that are undertaken during the initial few hours or days of an infant’s life. These tests have the potential to prevent several health problems and deaths. Newborn screening checks a baby for serious but rare and mostly treatable health conditions at birth. Newborn screening has evolved from a simple blood and urine screening test to a more comprehensive and complex screening system for detecting over 50 different conditions. Newborn screening tests measure different types of markers present in an infant’s blood that can either increase or decrease if the infant has certain diseases. Recently, conditions such as congenital hypothyroidism, phenylketonuria (PKU), cystic fibrosis (CF), and about 22 other metabolic conditions can be diagnosed through newborn screening tests that affect fat metabolism or protein. Thus, the introduction of such advanced products into the market is expected to drive the growth of the global newborn screening market over the forecast period.

Market Dynamics

The key players operating in the medical devices industry are focusing on organic activities such as product launches in the market, which is expected to drive growth of the global newborn screening market over the forecast period. For instance, in November 2021, Masimo, a medical device company, launched Dual SET Pulse Oximetry for Root, a highly versatile patient monitoring and connectivity hub. This enhances the automation of newborn screenings using Dual SET Oximetry: two simultaneous measurements of oxygen saturation (SpO2) at pre- and post-ductal sites by the intuitive Eve application, customized to align with a hospital’s CCHD screening protocol.

Key features of the study:

• This report provides an in-depth analysis of the global newborn screening market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023–2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global newborn screening market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Agilent Technologies, Inc., Bio-rad laboratories, Inc., Medtronic Plc, Masimo Corporation, Natus Medical Inc., Perkin Elmer, Inc, ZenTec S.A., Trivitron Healthcare Pvt Ltd, Waters Technologies Corporation, Danaher Corporation, Baebies, Inc , Parseq Lab Co. Ltd , Chromesystem Instruments and Chemicals GmbH , and RECIPE Chemicals+ Instrument GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global newborn screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global newborn screening market.

Newborn Screening Market Detailed Segmentation:

• By Product:
• Instruments
• Assay Kits
• Reagents
• By Test Type:
• Dry Blood Spot Test
• Cardiac Test
• Hearing Test
• Urine Test
• Others
• By Application:
• Phenylketonuria
• Critical Congenital Cardiac Disease
• Maple Syrup Urine Disease
• Hearing Disability
• Sickle Cell Disease
• Others
• By End User:
• Hospital
• Maternity and Specialty Clinics
• Diagnostic Centers
• By Region:
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
• Company Profiles
• Agilent Technologies, Inc.
• Bio-rad laboratories, Inc.
• Medtronic Plc
• Masimo Corporation
• Natus Medical Inc.
• Perkin Elmer, Inc
• ZenTec S.A.
• Trivitron Healthcare Pvt Ltd
• Waters Technologies Corporation
• Danaher Corporation
• Baebies, Inc
• Parseq Lab Co. Ltd
• Chromesystem Instruments and Chemicals GmbH
• RECIPE Chemicals+ Instrument GmbH